Fenwick & West represented Sceye in the transaction. Sceye, a leading U.S. aerospace company, announced its Series C funding. The round was led by Mawarid Holding...
Sceye’s Series C Funding Round
OrsoBio’s $67 Million Series B Funding Round
Fenwick & West represented OrsoBio in the transaction. OrsoBio,Inc. a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders, announced raising its $67 million Series...
Catio’s Funding Round
Fenwick & West represented Catio in the transaction. Catio announced it closed the oversubscribed Series PreSeed funding round, adding $2.6 million to the initial $1.4 million...
Oleria’s $33 Million Series A Financing Round
Fenwick & West represented Oleria in the transaction. Oleria announced it raised $33 million in a Series A funding round. This latest investment, which brings the company’s...
OrsoBio’s $60 Million Series A Financing Round
Fenwick & West represented OrsoBio in the transaction. OrsoBio, Inc. announced its $60 million Series A financing, bringing the total capital raised by the Company to $97 million....
Databricks’ $500 Million Series I Financing Round
Fenwick & West LLP represented Databricks in the transaction. Databricks announced its Series I funding, raising over $500 million. This funding values the company at $43 billion...
Shockwave Medical’s $750 Million Convertible Senior Notes Offering
Fenwick & West represented Shockwave Medical, Inc. in the transaction. Shockwave Medical, Inc. (Nasdaq: SWAV) announced its $750 million offering of 1.00% convertible senior notes due 2028...
Kira Learning’s $15 Million Series A Financing Round
Fenwick & West LLP represented Kira on the deal. Kira Learning, the company building an AI-powered platform that allows anyone to teach and learn computer science...
Vast’s Acquisition of Launcher
Fenwick represented Vast on the deal. Vast, a developer of space habitation technologies focused on expanding humanity across the solar system, announced its acquisition of Launcher, a...
Angle Health’s $58 Million Series A Financing
Fenwick represented Angle Health on the deal. Angle Health, a full-stack health insurance carrier delivering comprehensive healthcare benefits tailored to startups and technology companies, announced its $58...
Perceive Bio’s $78 Million Series B Financing
Fenwick represented Perceive Bio on the deal. Perceive Bio, a biotech company pioneering novel technologies and therapeutics in ophthalmology, announced its $78 million Series B financing. The...
The Arena Group’s Acquisition of Digital Assets from a360Media
Fenwick represented The Arena Group on the deal. The Arena Group (NYSE American: AREN), a tech-powered media company home to more than 240 brands, including Sports...